ATS 2019 Virtual Final Program

P791 Quantitative Analysis of Work of Breathing in Neonates with Bronchopulmonary Dysplasia Using Computational Fluid Dynamics/ C.C. Gunatilaka, A. Bates, N.S. Higano, L.M. Yoder, J.C. Woods, Cincinnati, OH, p.A5487 P792 Susceptibility to Oxidative Stress Characterizes Phenotypes in Murine Model of BPD/ T. Mizutani, A. Sato, A. Watanabe, Y. Hamakawa, K. Uemasu, N. Tanabe, S. Sato, T. Hirai, Kyoto, Japan, p.A5488 P793 Antenatal Endotoxin Impairs Lung Mechanical Function and Increases Sensitivity to Ventilator-Induced Lung Injury in Newborn Rat Pups/ B.J. Smith, C. Mattson, G. Seedorf, S. Ryan, T. Gonzalez, A. Wallbank, S.H. Abman, E. Mandell, Aurora, CO, p.A5489 P794 The Effect of Mother’s Own Milk on Respiratory Severity Score in Very Low Birth Weight Infants/ K. Sapp, C. Bauza, P. Parimi, M. Newkirk, M. Go, St. Peterbusrg, FL, p.A5490 Facilitator : Y.S. Prakash, MD, PhD, Rochester, MN P795 Continuous Positive Airway Pressure (CPAP) Therapy Increases Alveolarization in a Nonhuman Primate Model of Moderately Preterm Birth, a Randomized Trial/ C.T. McEvoy, M.H. Davies, K.D. MacDonald, K.C. Lund, R. Lam, L.E. Shorey-Kendrick, B.L. Dozier, L.D. Martin, S. O’Sullivan, J. Schoen, R.S. Tepper, E.R. Spindel, Portland, OR, p.A5491 P796 Automated Whole Slide Morphometry (AWSM-Q): A Validation Study for Lung Histology Quantification in Rodent Models of Bronchopulmonary Dysplasia/ A. Lindenmaier, S. Sadanand, J. Zheng, B. Zanette, Y. Friedlander, M. Couch, E. Stirrat, S. Bouch, I. Lok, J. Ivanovska, M. Post, R.P. Jankov, G. Santyr, Toronto, Canada, p.A5492 P797 Magnetic Resonance Spectroscopy of Hyperpolarized 129 Xe in a Rat Model of Bronchopulmonary Dysplasia: Effect on Red Blood Cell Chemical Shift in the Lungs/ Y. Friedlander, B. Zanette, A. Lindenmaier, E. Stirrat, D. Li, M. Couch, M. Post, R.P. Jankov, A. Kassner, G. Santyr, Toronto, Canada, p.A5493 P798 Moderate Hyperoxia Induces Senescence in Human Fetal Lung Fibroblasts/ K. You, P. Parikh, K. Khandalavala, S.A. Wicher, B. Yang, A.M. Roesler, L. Manlove, B. Roos, C.M. Pabelick, Y.S. Prakash, Shenyang, China, p.A5494 P799 In Utero Exposure to Ionizing Radiation and the Respiratory Response to an Acute Lung Injury Stimulus at Adolescence/ J. McEvoy, S. Sreetharan, L. Stoa, D.-L. Dixon, T.C. Tai, A.M. Hooker, D. Boreham, J. Wilson, Bedford Park, Australia, p.A5495 P800 Ventilatory Pattern Variability and Brainstem Inflammation in an E. coli Sepsis Model/ S. Tackett, N. Solanki, C. Clifford, C. Campanaro, K.-K. Horton, D.R. Fletcher, D.E. Nethery, Y.-H.H. Hsieh, T.L. Bonfield, T.E. Dick, F. Jacono, Cleveland, OH, p.A5496 BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION C71 PULMONARY HYPERTENSION 9:15 a.m. - 4:15 p.m. KBHCCD Area J (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitator : M. Eghbali, PhD, Los Angeles, CA P1187 Role of Slug/PIP Axis in Vascular Remodeling in Pulmonary Hypertension Secondary to Pulmonary Fibrosis/ G. Ruffenach, M. Vaillancourt, D. younessi, F. Sy, N. Cao, C. Cunningham, R. Saggar, S. Reddy, S. Umar, G. Fishbein, M. Eghbali, Los Angeles, CA, p.A5497 P1188 Thymic Stromal Lymphopoietin Role in Human Pulmonary Artery Smooth Muscle Proliferation and Contractility/ B. Roos, M. Thompson, S. Venkatachalem, L. Manlove, J. Miller, C.M. Pabelick, Y.S. Prakash, Rochester, MN, p.A5498 P1189 CXC-Chemokine Ligand 10 as a Biomarker for Chronic Thromboembolic Pulmonary Hypertension/ R. McDowell, L. Tian, R.A. Dweik, G.A. Heresi, Cleveland, OH, p.A5499 P1190 Niclosamide Ameliorates Experimental Pulmonary Hypertension by Reducing Endothelial-Mesenchymal Transition/ C.L. Braga, N.S. Felix, C.M. Barbosa, J. Borges Vieira, D. Esteves Teixeira, M.A.A. Almeida, N.D.N. Rocha, C.C. Neves, P.R.M. Rocco, F.F. Cruz, P.L. Silva, Rio de Janeiro, Brazil, p.A5500 P1191 Temporal Echocardiographic Assessment of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib, Pirfenidone and Other Agents/ M. Tahara, K. Oda, K. Yamasaki, K. Yatera, Kitakyushu City, Japan, p.A5501 Facilitator : S. Dua, MD, New York, NY P1192 Correlation of FVC/DLCO to Mean Pulmonary Artery Pressure in Scleroderma-Associated Pulmonary Artery Hypertension/ S. Korzan, C. Halasan, R.J. Foley, D. Datta, Farmington, CT, p.A5502 P1193 Significance of End-Tidal PCO2 and Its Relation to Functional Capacity in IPAH and CTEPH Patients/ J. Liu, X. Shi, J. Guo, L. Wang, Q. Zhao, S. Gong, Shanghai, China, p.A5503 P1194 Value of Heart Rate Recovery in Female Patients with Pulmonary Arterial Hypertension Due to Systemic Lupus Erythematosus/ J. Liu, G. Yang, J. Guo, W. Yang, L. Wang, Q. Zhao, S. Gong, Shanghai, China, p.A5504 P1195 Difference in Exercise Capacity and Ventilatory Efficiency Between Chronic Obstructive Pulmonary Disease Associated Pulmonary Hypertension and Idiopathic Pulmonary Hypertension/ J. Liu, H. Liu, J. Guo, L. Wang, Q. Zhao, S. Gong, Shanghai, China, p.A5505 ATS 2019 • Dallas, TX TUESDAY • MAY 21 285 TUESDAY MORNING